These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 28382135)
21. Identification of the prognostic value of lymphocyte-to-monocyte ratio in patients with HBV-associated advanced hepatocellular carcinoma. Hong YF; Chen ZH; Wei L; Ma XK; Li X; Wen JY; Wang TT; Cai XR; Wu DH; Chen J; Ruan DY; Lin ZX; Lin Q; Dong M; Wu XY Oncol Lett; 2017 Aug; 14(2):2089-2096. PubMed ID: 28789436 [TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of the pre-chemotherapy lymphocyte-to-monocyte ratio in patients with previously untreated metastatic colorectal cancer receiving FOLFOX chemotherapy. Lin GN; Liu PP; Liu DY; Peng JW; Xiao JJ; Xia ZJ Chin J Cancer; 2016 Jan; 35():5. PubMed ID: 26740116 [TBL] [Abstract][Full Text] [Related]
23. The lymphocyte-to-monocyte ratio could predict the efficacy of PD-1 inhibitors in patients with advanced cancer. Xiao L; Li L; Chen G; Zhang Y; Gao Q Transl Cancer Res; 2020 Jul; 9(7):4111-4120. PubMed ID: 35117780 [TBL] [Abstract][Full Text] [Related]
24. Peripheral Blood Lymphocyte-to-Monocyte Ratio as a Useful Prognostic Factor in Newly Diagnosed Multiple Myeloma. Tian Y; Zhang Y; Zhu WQ; Chen XL; Zhou HB; Chen WM Biomed Res Int; 2018; 2018():9434637. PubMed ID: 30599001 [TBL] [Abstract][Full Text] [Related]
25. Primary debulking surgery versus primary neoadjuvant chemotherapy for high grade advanced stage ovarian cancer: comparison of survivals. Kobal B; Noventa M; Cvjeticanin B; Barbic M; Meglic L; Herzog M; Bordi G; Vitagliano A; Saccardi C; Skof E Radiol Oncol; 2018 Sep; 52(3):307-319. PubMed ID: 30210049 [TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of the preoperative lymphocyte-to-monocyte ratio in patients with colorectal cancer. Shibutani M; Maeda K; Nagahara H; Iseki Y; Ikeya T; Hirakawa K Oncol Lett; 2017 Feb; 13(2):1000-1006. PubMed ID: 28356991 [TBL] [Abstract][Full Text] [Related]
27. Prognostic value of lymphocyte-to-monocyte ratio in ovarian cancer: A meta-analysis. Lu C; Zhou L; Ouyang J; Yang H Medicine (Baltimore); 2019 Jun; 98(24):e15876. PubMed ID: 31192919 [TBL] [Abstract][Full Text] [Related]
28. Correlation analysis of lymphocyte-monocyte ratio with pathological complete response and clinical prognosis of neoadjuvant chemotherapy in patients with breast cancer. Meng X; Wang X; Jiang C; Zhang S; Cheng S Transl Oncol; 2022 Apr; 18():101355. PubMed ID: 35121221 [TBL] [Abstract][Full Text] [Related]
29. [Impact of preoperative lymphocyte to monocyte ratio on the prognosis of the elderly patients with stage II(-III( gastric cancer]. Cong X; Li S; Xue Y Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Oct; 19(10):1144-1148. PubMed ID: 27781252 [TBL] [Abstract][Full Text] [Related]
30. Primary debulking surgery vs. neoadjuvant chemotherapy followed by interval debulking surgery for patients with advanced ovarian cancer. Bian C; Yao K; Li L; Yi T; Zhao X Arch Gynecol Obstet; 2016 Jan; 293(1):163-168. PubMed ID: 26198168 [TBL] [Abstract][Full Text] [Related]
31. Peripheral Blood Lymphocyte-to-Monocyte Ratio at Relapse Predicts Outcome for Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma in the Rituximab Era. Katoh D; Ochi Y; Yabushita T; Ono Y; Hiramoto N; Yoshioka S; Yonetani N; Matsushita A; Hashimoto H; Kaji S; Imai Y; Ishikawa T Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):e91-e97. PubMed ID: 28918104 [TBL] [Abstract][Full Text] [Related]
32. Combined prognostic value of absolute lymphocyte/monocyte ratio in peripheral blood and interim PET/CT results in Hodgkin lymphoma. Simon Z; Barna S; Miltenyi Z; Husi K; Magyari F; Jona A; Garai I; Nagy Z; Ujj G; Szerafin L; Illes A Int J Hematol; 2016 Jan; 103(1):63-9. PubMed ID: 26462809 [TBL] [Abstract][Full Text] [Related]
36. Pretreatment Lymphocyte to Monocyte Ratio is an Independent Prognostic Factor in Metastatic Clear Cell Renal Cell Carcinoma. Gu L; Ma X; Xie Y; Li H; Wang L; Chen L; Zhao W; Zhang Y; Zhang X Clin Genitourin Cancer; 2017 Jun; 15(3):e369-e377. PubMed ID: 28038932 [TBL] [Abstract][Full Text] [Related]
37. Pretreatment lymphocyte to monocyte ratio as a predictor of prognosis in patients with early-stage triple-negative breast cancer. He J; Lv P; Yang X; Chen Y; Liu C; Qiu X Tumour Biol; 2016 Jul; 37(7):9037-43. PubMed ID: 26762408 [TBL] [Abstract][Full Text] [Related]
38. Combined Preoperative LMR and CA125 for Prognostic Assessment of Ovarian Cancer. Tang Y; Hu HQ; Tang FX; Lin D; Shen R; Deng L; Tang YL; Deng LH; Zhou M; Li J; Su B; Xu F J Cancer; 2020; 11(11):3165-3171. PubMed ID: 32231720 [No Abstract] [Full Text] [Related]
39. Preoperative lymphocyte-to-monocyte ratio represents a superior predictor compared with neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios for colorectal liver-only metastases survival. Peng J; Li H; Ou Q; Lin J; Wu X; Lu Z; Yuan Y; Wan D; Fang Y; Pan Z Onco Targets Ther; 2017; 10():3789-3799. PubMed ID: 28794643 [TBL] [Abstract][Full Text] [Related]
40. Lymphocyte to monocyte ratio is associated with response to first-line platinum-based chemotherapy and prognosis of early-stage non-small cell lung cancer patients. Song YJ; Wang LX; Hong YQ; Lu ZH; Tong Q; Fang XZ; Tan J Tumour Biol; 2016 Apr; 37(4):5285-93. PubMed ID: 26561466 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]